Drawing for ONCONETICS

USPTO serial 87238872

ONCONETICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FERRELL, STEVEN WAYNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCONETICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret C. McHugh

MARGARET C. MCHUGH KILPATRICK TOWNSEND & STOCKTON LLP1100 PEACHTREE STREET, SUITE 2800MAILSTOP: IP DOCKETING - 22ATLANTA, GA 30309

Goods and services

ClassDescriptionStatusFirst use
042research and development in the fields of pharmaceuticals, drug development, biomarker discovery, diagnostics, genomics, genetic research, biopharmaceuticals and therapeutics; research and development in the field of personalized medicine and its delivery to patients; research and development of personalized cancer treatments; scientific research, development, engineering, testing, and analytical services in the fields of medicine, pharmaceuticals, genetics, and oncology; biological research, namely, biological sample characterization, screening, and analysis services for scientific research purposes; medical and scientific research in the fields of diseases and diagnosing and treating diseases; providing medical testing services in the field of cancer research and disease classification; laboratory testing services, namely, conducting medical tests on biological samples for scientific research purposesACTIVE—
044medical testing for diagnostic or treatment purposes; laboratory testing services, namely, conducting medical tests on biological samples for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 18, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 17, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 3, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 1, 2019EX4GSOU EXTENSION 4 GRANTED—
Jul 1, 2019EXT4SOU EXTENSION 4 FILED—
Jul 1, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2019EX3GSOU EXTENSION 3 GRANTED—
Jan 4, 2019EXT3SOU EXTENSION 3 FILED—
Jan 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 21, 2018EX2GSOU EXTENSION 2 GRANTED—
May 21, 2018EXT2SOU EXTENSION 2 FILED—
May 21, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2018EX1GSOU EXTENSION 1 GRANTED—
Jan 9, 2018EXT1SOU EXTENSION 1 FILED—
Jan 9, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 9, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 11, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 16, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 16, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 11, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 30, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 10, 2017ALIEASSIGNED TO LIE—
Feb 23, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 23, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 23, 2017EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Feb 23, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Feb 23, 2017DOCKASSIGNED TO EXAMINER—
Nov 22, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance